📚 Part of our Blood Sugar Guide — an evidence-based guide.
For a hundred years, a type 1 diabetes diagnosis has meant one thing: a lifetime tethered to insulin — injections or a pump, blood-sugar checks, and the constant vigilance of managing a disease that never takes a day off. Now, for the first time, that story is changing. In recent clinical trials, a handful of people with type 1 diabetes have started producing their own insulin again — after receiving insulin-making cells grown in a lab from stem cells. It is one of the most remarkable advances in modern medicine, and it deserves to be understood clearly: what’s genuinely real, and what isn’t yet.
What type 1 diabetes actually is
Type 1 diabetes is an autoimmune disease. The body’s immune system mistakenly destroys the beta cells in the pancreas — the cells that make insulin, the hormone that lets your body use blood sugar for energy. Without those cells, glucose builds up dangerously, and survival depends on injected insulin. Crucially, this is different from the far more common type 2 diabetes, which is driven by insulin resistance rather than an autoimmune attack.
The breakthrough
Scientists have learned to coax stem cells into becoming functioning islet cells — the clusters that contain insulin-producing beta cells — and infuse them into patients. Once established, these new cells do what a healthy pancreas does: sense rising blood sugar and release insulin in response. In trials reported in the New England Journal of Medicine, some participants achieved insulin independence, no longer needing injected insulin at all. A 2025 review in the journal Diabetes on advances in cell-replacement therapy lays out just how far this field has come — from a distant dream to a documented reality in real patients.
Why is this such a big deal? Because it doesn’t just manage the symptoms of diabetes — it replaces the missing cells at the root of the disease. That’s a fundamentally different kind of medicine, and it’s the closest anyone has come to a true cure.
The honest limits — and they matter
This is where responsible reporting matters most, because the word “cure” carries enormous emotional weight for millions of families. Here is the sober picture:
- It requires immunosuppression. The same immune system that caused type 1 diabetes will also attack the new cells, so recipients currently take powerful immune-suppressing drugs. Those drugs carry real risks — infection, among others — which is why the therapy is, for now, reserved for people with severe, dangerous diabetes (such as life-threatening hypoglycemia they can’t feel coming).
- It’s not widely available. This is early-stage, trial-and-early-approval territory — not something you can ask your doctor for on a routine visit today.
- It’s for type 1, not type 2. If you have type 2 diabetes, this specific breakthrough doesn’t apply to your condition.
What comes next
The next frontier is removing the need for immunosuppression — by encapsulating the cells to shield them, or gene-editing them to be “invisible” to the immune system. That work is underway and still experimental. If it succeeds, a treatment that today fits a small group of severe cases could one day reach far more people.
The bottom line
This is real, grounded hope — not hype. For the first time, science has shown that the insulin-making cells lost in type 1 diabetes can be replaced, and that people can live without injected insulin as a result. It is a genuine landmark. It is also still early, still limited, and not yet a cure available to the public. If you or someone you love has type 1 diabetes, the right move is a conversation with an endocrinologist about where this science stands — and real optimism about the direction it’s heading.
This article is for general education and is not medical advice. Talk with your doctor about your own care, especially regarding any medical condition or treatment.
Frequently asked questions
Is there a cure for type 1 diabetes yet?
Not a widely available one, but there's been a historic advance: in clinical trials, lab-grown islet cells restored insulin production in some people with type 1 diabetes, achieving insulin independence. It's a functional cure in a small, controlled setting, not yet a treatment most people can get.
Does the stem-cell treatment work for type 2 diabetes?
No. This therapy replaces the insulin-producing cells destroyed in type 1 (autoimmune) diabetes. Type 2 diabetes has a different cause, so this approach doesn't apply to it.
Why do patients still need immunosuppression?
Because the immune system attacks the transplanted cells, patients currently take immune-suppressing drugs, which carry their own risks. That's why it's reserved for severe cases, and why researchers are working to make cells that don't need immunosuppression.